Organovo Holdings Shares Corporate Update Presentation

TipRanksMay 1 20:23

INVO, EZGO and WISA Among Pre-market Losers

Seeking AlphaApr 18 20:15

Significant reduction in liver fat! Organovo Holdings (ONVO.US) announces positive trial results for MASH therapy

Organovo Holdings (ONVO.US) announced the positive results of its phase 2 trial of the drug FXR314 for the treatment of patients with metabolic function-related steatohepatitis (MASH).

Zhitong FinanceApr 16 21:29

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersDynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap stands at $3.3 million. BioRestorative Therapies (NASDAQ:BRTX) shares rose 23.4

BenzingaApr 16 20:07

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d

BenzingaApr 16 02:11

Why Organovo Stock Is Up Today

Organovo Holdings, Inc. (NASDAQ:ONVO) shares are trading higher Monday after the company announced Phase 2 results for FXR314. The Details:Organovo released the complete details of its 16-week, random

BenzingaApr 15 22:56